Genesco (NYSE:GCO – Get Free Report) updated its FY 2027 earnings guidance on Friday. The company provided EPS guidance of 1.900-2.300 for the period, compared to the consensus EPS estimate of 2.050. The company issued revenue guidance of $2.4 billion-$2.4 billion, compared to the consensus revenue estimate of $2.5 billion.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on GCO. Truist Financial set a $38.00 price objective on shares of Genesco in a report on Wednesday, January 14th. UBS Group set a $38.00 price objective on Genesco in a research note on Friday, December 5th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Genesco in a report on Wednesday, December 24th. Williams Trading raised shares of Genesco to a “strong-buy” rating in a research report on Monday, January 12th. Finally, Wall Street Zen downgraded shares of Genesco from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Genesco has an average rating of “Hold” and an average price target of $36.00.
Check Out Our Latest Research Report on Genesco
Genesco Stock Performance
Genesco (NYSE:GCO – Get Free Report) last issued its earnings results on Friday, March 6th. The company reported $3.74 EPS for the quarter, beating analysts’ consensus estimates of $3.73 by $0.01. Genesco has set its FY 2027 guidance at 1.900-2.300 EPS. As a group, research analysts expect that Genesco will post 0.94 earnings per share for the current year.
Institutional Trading of Genesco
A number of hedge funds have recently added to or reduced their stakes in GCO. Fund 1 Investments LLC raised its position in shares of Genesco by 3.5% in the fourth quarter. Fund 1 Investments LLC now owns 986,241 shares of the company’s stock worth $24,429,000 after acquiring an additional 33,044 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Genesco by 23.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 409,227 shares of the company’s stock worth $10,137,000 after purchasing an additional 76,494 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its position in Genesco by 50.0% during the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 300,000 shares of the company’s stock worth $7,431,000 after purchasing an additional 100,000 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Genesco by 6.7% in the third quarter. Arrowstreet Capital Limited Partnership now owns 290,639 shares of the company’s stock valued at $8,426,000 after buying an additional 18,184 shares in the last quarter. Finally, Bridgeway Capital Management LLC grew its stake in Genesco by 29.7% in the 2nd quarter. Bridgeway Capital Management LLC now owns 238,252 shares of the company’s stock valued at $4,691,000 after acquiring an additional 54,498 shares during the period. 94.51% of the stock is owned by hedge funds and other institutional investors.
About Genesco
Genesco Inc is a Nashville, Tennessee-based retailer, wholesaler and licensee specializing in branded footwear, headwear, apparel and accessories. Through its portfolio of retail chains, wholesale distribution channels and licensing agreements, Genesco brings a range of product offerings to consumers in North America and Europe.
The company’s retail segment includes specialty chains such as Journeys, which targets fashion-focused teens and young adults in the United States and Canada, and Schuh, a footwear retailer with locations in the United Kingdom and Ireland.
Read More
- Five stocks we like better than Genesco
- Buy this Gold Stock Before May 15th, 2026
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.
